Leisure sitting time associated with increased risk of cancer in women
the ONA take:
According to a study published in the journal Cancer Epidemiology, Biomarkers & Prevention, researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.
For the study, researchers analyzed data from more than 146,000 men and women included in the American Cancer Society Cancer Prevention Study II Nutrition Cohort to compare leisure time sitting with cancer risk. Of the 77,462 women and 69,260 men, 12,236 women and 18,555 men were diagnosed with cancer between 1992 and 2009.
Results showed that leisure time sitting was associated with a 10% increased risk for developing cancer in women after adjusting for confounding factors, such as body mass index, physical activity, and other factors. Researchers found no association between sitting time and cancer risk in men.
The study demonstrated that sitting time was associated with an increased risk for developing invasive breast cancer, multiple myeloma, and ovarian cancer in women.
The authors note that further research is warranted to better understand the differences in associations of sitting time and cancer risk between men and women.
Researchers have found that spending more leisure time sitting was associated with an increased risk for developing cancer in women.
Sign Up for Free e-newsletters
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
- Mindfulness Training May Improve End-of-Life Conversations in Advanced Cancer
- Study Suggests Greater Focus on the Needs of Family Caregivers of Patients With Cancer
- First Antibody-Based Treatment Regimen Approved for First-Line Treatment of Multiple Myeloma
- Increased Diabetes Risk Associated With Cancer Development
- Childhood Neuroblastoma Survivors at Risk for Psych Impairment
- Drug Classification of Trastuzumab
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|